KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Depreciation and Depletion (2022 - 2025)

Twist Bioscience (TWST) has disclosed Depreciation and Depletion for 4 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 3.28% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.8 million through Dec 2025, down 10.19% year-over-year, with the annual reading at $23.8 million for FY2025, 12.82% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $5.9 million at Twist Bioscience, up from $5.7 million in the prior quarter.
  • The five-year high for Depreciation and Depletion was $7.3 million in Q3 2023, with the low at $3.9 million in Q4 2022.
  • Average Depreciation and Depletion over 4 years is $6.2 million, with a median of $6.4 million recorded in 2024.
  • The sharpest move saw Depreciation and Depletion surged 76.92% in 2023, then decreased 17.14% in 2025.
  • Over 4 years, Depreciation and Depletion stood at $3.9 million in 2022, then skyrocketed by 76.92% to $6.9 million in 2023, then decreased by 11.59% to $6.1 million in 2024, then dropped by 3.28% to $5.9 million in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $5.9 million, $5.7 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.